Isolation and Properties of Cytotoxic Polyene Antibiotics Produced by Myxococcus stipitatus JW117.

Myxococcus stipitatus JW117이 생산하는 Polyene계 세포독성 물질의 분리 및 특성

  • 안종웅 (한국화학연구원 생명의약부) ;
  • 최상운 (한국화학연구원 생명의약부) ;
  • 권호정 (세종대학교 공과대학 생명공학과)
  • Published : 2002.06.01

Abstract

Drug resistance is one of the most significant impediments to successful chemotherapy of cancer. Multidrug-resistance (MDR) is characterized by decreased cellular sensitivity to anticancer agents due to the overexpression of P-glycoprotein. By employing adriamycin-resistance CL02 cancer cells, we undertook the screening for agents which were effective to multidrug-resistant cancer cells. As a result, a myxobacterial strain JW117 was selected for study since the solvent extract of cell mass of the strain was found to exhibit significant activity against the CL02 cancer cells. Cytotoxicity-guided chromatographic fractionation led to the isolation of phenalamides $A_2$ and $A_3$. The producing organism was identified as Myxococcus stipitatus by taxonomic comparison with type strains of Myxococcus sp. as well as its morphological and physiological characteristics. Phenalamides$ A_1$,$ A_2$ and $A_3$ were as active against drug-resistant cancer cells CL02 and CP70 as against the corresponding sensitive cells with $IC_{50}$ values ranging from 0.23~0.57 $\mu\textrm{g}$/ml.

암세포가 특정 항암제에 의해 내성을 획득하면 구조가 상이한 타 항암제에도 교차내성을 나타내는 이른바 암세포의 다약제 내성(MDR)이 암 화학요법에 있어서 가장 심각한 문제가 되고 있다. 본 연구에서는 다약제 내성 암세포주인 CL02 세포를 이용하여 점액세균의 대사산물을 대상으로 다약재 내성 암세포에 유효한 항암물질을 탐색하는 과정에서, Myxococcus stipitatus로 동정된 JW117 균주의 대사산물에서 우수한 활성을 발견하고 그 활성본체로서 polyene계 화합물인 phenalamides $A_1$, $A_2$, $A_3$를 분리하였다. Phenalamides $A_1$, $A_2$, $A_3$는 인체기원의 암세포에 대해 모두 강한 세포독성($IC_{50}$/ : 0.23~0.57 $\mu\textrm{g}$/ml)을 나타낼 뿐 아니라 다약제내성 세포주인 CL02와 cisplatin내성 세포주인 CP70에 대해서도 감수성 세포주와 동일한 활성을 나타내어 다약제 내성을 극복하는 우수한 활성 물질임을 확인하였다.

Keywords

References

  1. Biochim. Biophys. Acta. v.948 Mechanism of multidrug resistance Bradley, G.;P. F. Juranka;V. Ling
  2. Arch. Pharm. Res. v.19 Establishment of doxorubicin-resistant subline derived from HCT15 human colorectal cencer cells Choi, S. U.;N. Y. Kim;E. J. Choi;K. H. Kim;C. O. Lee https://doi.org/10.1007/BF02976376
  3. J. Antibiotics v.38 The corallopyronins, new inhibitors of bacterial RNA synthesis from myxobacteria Irschik, H.;R. Jansen;G. Hoefle;K. Gerth;H. Reichenbach https://doi.org/10.7164/antibiotics.38.145
  4. Anticancer Res. v.11 Establishment of multidrug resistant human colorectal carcinoma HCT15 cell line and their properties Iwahashi, T.;E. Okochi;C. Ono;L. Sugawara;T. Tsuruo;S. Mori
  5. Antiviral Chemistry & Chemotherapy v.3 Three new potent HIV-1 inhibitors from myxobacteria Jurkiewicz, E.;R. Jansen;B. Kunze;W. Trowitzsch-Kienast;E. Forche;H. Reichenbach;G. Hoefle;G. Hunsmann https://doi.org/10.1177/095632029200300401
  6. J. Antibiotics v.44 Isolation and structural elucidation of stipiamide, a new antibiotic effective to multidrug-resistant cancer cells Kim, Y. J.;K. Furihata;S. Yamanaka;R. Fudo;H. Seto https://doi.org/10.7164/antibiotics.44.553
  7. Pharmacotherapy v.13 Molecular targets in oncology: implications of the multidrug resistance gene Lum, B. L.;M. P. Gosland;S. Kaubisch;B. I. Sikic
  8. Cancer v.71 Mechanisms and modulation of resistance to chemotherapy in ovarian cancer Perez, R. P.;T. C. Hamilton;R. F. Ozoles;R. C. Young https://doi.org/10.1002/cncr.2820710424
  9. The Prokaryotes (2nd ed.) The Myxobacteria Reichenbach, H.;M. Dworkin;Balowsm, A.(eds.);H. G. Truper(eds.);M. Dworkin(eds.)
  10. J. Nat. Cancer Inst. v.82 New colorimetric cytotoxicity assay for anticancer drug screening Skehan, P.;R. Storeng;D. Scudiero;A. Monks;J. McMahon;D. Vistica;J. Warren;H. Bokesch;S. Kenny;M. R. Boyd https://doi.org/10.1093/jnci/82.13.1107
  11. Liebigs Ann. Chem. v.1992 Phenalamide, neus HIV-1 inhibitoren aus M. stipitatus Mxs40 Trowitzsch-Kienast, W.;E. Forche;V. Wray;H. Reichenbach;E. Jurkiewicz;G. Hunsmann;G. Hoefle https://doi.org/10.1002/jlac.1992199201112
  12. Proc. Natl. Acad. Sci. USA. v.84 Expression of a full length cDNA for the human MDR-1 gene confers resistance to colchicine, doxorubicin, and vinblastin Ueda, K.;G. Cardarelli;M. M. Gottesman;I. Pastan https://doi.org/10.1073/pnas.84.9.3004
  13. J. Gen. Appl. Microbiol. v.33 Isolation and identification of myxobacteria Yamanaka, S.;A. Kawaguchi;K. Komagata https://doi.org/10.2323/jgam.33.247